Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06600256 · ClinicalTrials.gov registry record
Viz HCM (ECG Assist) Utilization Workflow Pilot
A clinical trial, sponsored by Viz.ai.
- Completed
- Registry status
- 217
- Enrollment target
NCT06600256: Completed study, sponsored by Viz.ai.
NCT06600256 is a clinical trial that has completed, run by Viz.ai. The registered enrollment target is 217 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06600256 has completed, sponsored by Viz.ai.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
Study Summary
This is a prospective, open-label, multi-center workflow pilot. Viz HCM will be implemented at each participating site and all conforming incoming ECG recordings within a 6-month enrollment period will be analyzed using Viz HCM. This workflow pilot provides an opportunity to understand how Viz HCM will be utilized and adopted post-market and to learn the pre- versus post-implementation impact of Viz HCM on HCM clinical workflow. This pilot is designed to evaluate the implementation of Viz HCM for use in traditional HCM clinical workflow. Findings from this pilot will help inform the following: * The impact of Viz HCM on HCM clinical workflow * How Viz HCM will be utilized and adopted post-market * The diversity in the HCM patient population and the variation in HCM clinical workflow
Primary Outcome
Algorithm performance - sensitivity and specificity of the Viz HCM software
Interventions
- BEHAVIORAL Viz HCM ECG Review
- BEHAVIORAL Baseline Effectiveness Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2024-06-30 |
What the finished NCT06600256 record still lists
NCT06600256 is an observational study that tracks outcomes without assigning an intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Viz HCM ECG Review is the first listed.
NCT06600256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06600256 about?
NCT06600256 is a clinical study titled "Viz HCM (ECG Assist) Utilization Workflow Pilot". This is a prospective, open-label, multi-center workflow pilot. Viz HCM will be implemented at each participating site and all conforming incoming ECG recordings within a 6-month enrollment period will be analyzed using Viz HCM. This workflow pilot provides an opportunity to understand how Viz HCM w...
What is the current status of trial NCT06600256?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2022-01-10. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT06600256?
The interventions under investigation include: Viz HCM ECG Review (BEHAVIORAL), Baseline Effectiveness Cohort (BEHAVIORAL).
Who is sponsoring clinical trial NCT06600256?
This trial is sponsored by Viz.ai, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI